Source:http://linkedlifedata.com/resource/pubmed/id/16646070
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
2006-8-24
|
pubmed:abstractText |
Persistent infection with high-risk human papillomavirus (HPV) is central to cervical carcinogenesis. Certain high-risk types, such as HPV16, may be more persistent than other HPV types, and type-specific HPV persistence may differ by HIV serostatus. This study evaluated the association between HPV type and clearance of HPV infections in 522 HIV-seropositive and 279 HIV-seronegative participants in the HIV Epidemiology Research Study (HERS, United States, 1993-2000). Type-specific HPV infections were detected using MY09/MY11/HMB01-based PCR and 26 HPV type-specific probes. The estimated duration of type-specific infections was measured from the first HPV-positive visit to the first of two consecutive negative visits. Hazard ratios (HRs) and 95% confidence intervals (CIs) for HPV clearance were calculated using Cox models adjusted for study site and risk behavior (sexual or injection drugs). A total of 1,800 HPV infections were detected in 801 women with 4.4 years median follow-up. HRs for clearance of HPV16 and related types versus low-risk HPV types were 0.79 (95% CI: 0.64-0.97) in HIV-positive women and 0.86 (95% CI: 0.59-1.27) in HIV-negative women. HRs for HPV18 versus low-risk types were 0.80 (95% CI: 0.56-1.16) and 0.57 (95% CI: 0.22-1.45) for HIV-positive and -negative women, respectively. HPV types within the high-risk category had low estimated clearance rates relative to low-risk types, but HRs were not substantially modified by HIV serostatus.
|
pubmed:grant |
http://linkedlifedata.com/resource/pubmed/grant/5 P30 AI050410-07,
http://linkedlifedata.com/resource/pubmed/grant/CA09330-22,
http://linkedlifedata.com/resource/pubmed/grant/U64/CCU106795,
http://linkedlifedata.com/resource/pubmed/grant/U64/CCU206798,
http://linkedlifedata.com/resource/pubmed/grant/U64/CCU306802,
http://linkedlifedata.com/resource/pubmed/grant/U64/CCU506831
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0020-7136
|
pubmed:author |
pubmed-author:CelentanoDavidD,
pubmed-author:Cu-UvinSusanS,
pubmed-author:DuerrAnnA,
pubmed-author:HeiligCharles MCM,
pubmed-author:JamiesonDenise JDJ,
pubmed-author:KleinRobert SRS,
pubmed-author:KoshiolJill EJE,
pubmed-author:MarshallStephen WSW,
pubmed-author:SchroederJane CJC,
pubmed-author:SchumanPaulaP,
pubmed-author:ShahKeerti VKV,
pubmed-author:SmithJennifer SJS
|
pubmed:copyrightInfo |
Copyright 2006 Wiley-Liss, Inc.
|
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
119
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1623-9
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:16646070-Adult,
pubmed-meshheading:16646070-Female,
pubmed-meshheading:16646070-HIV,
pubmed-meshheading:16646070-HIV Infections,
pubmed-meshheading:16646070-Humans,
pubmed-meshheading:16646070-Male,
pubmed-meshheading:16646070-Papillomaviridae,
pubmed-meshheading:16646070-Papillomavirus Infections,
pubmed-meshheading:16646070-Risk Factors,
pubmed-meshheading:16646070-Time Factors
|
pubmed:year |
2006
|
pubmed:articleTitle |
Time to clearance of human papillomavirus infection by type and human immunodeficiency virus serostatus.
|
pubmed:affiliation |
Department of Epidemiology, University of North Carolina, Chapel Hill, NC, USA. koshiolj@mail.nih.gov
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, N.I.H., Extramural
|